<?xml version="1.0" encoding="UTF-8"?>
<ref id="pmed.1002882.ref063">
 <label>63</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Jindani</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Harrison</surname>
   <given-names>TS</given-names>
  </name>, 
  <name>
   <surname>Nunn</surname>
   <given-names>AJ</given-names>
  </name>, 
  <name>
   <surname>Phillips</surname>
   <given-names>PP</given-names>
  </name>, 
  <name>
   <surname>Churchyard</surname>
   <given-names>GJ</given-names>
  </name>, 
  <name>
   <surname>Charalambous</surname>
   <given-names>S</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>High-dose rifapentine with moxifloxacin for pulmonary tuberculosis</article-title>. 
  <source>N Engl J Med</source>. 
  <year>2014</year>;
  <volume>371</volume>(
  <issue>17</issue>):
  <fpage>1599</fpage>â€“
  <lpage>608</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa1314210</pub-id>
  <?supplied-pmid 25337749?>
  <pub-id pub-id-type="pmid">25337749</pub-id>
 </mixed-citation>
</ref>
